Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bone mineral matrix, primarily composed of hydroxyapatite (Ca10(PO4)6(OH)2), is the inorganic component of bone that provides rigidity and strength. It serves as a reservoir for calcium and phosphate and is essential for bone remodeling and overall skeletal health. While it is not a direct therapeutic target, its formation and resorption are influenced by various drugs targeting bone metabolism. The matrix is a composite of hydroxyapatite nanocrystals embedded in a collagenous organic matrix.
Bisphosphonates bind to hydroxyapatite and inhibit osteoclast activity, reducing bone resorption.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Mineral Matrix (Hydroxyapatite) (Hydroxyapatite).